Skip to main content
SRPT logo

Sarepta Therapeutics, Inc.

SRPTNASDAQHealthcareBiotechnology

$17.98Today:- (-)1Y −16.95%

As of Oct 26, 2026 close

Market cap
$1.90B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$14.68$24.68
Volume (live)
-
Avg. volume (3M)
2.90M

Sarepta Therapeutics, Inc. (SRPT) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Sarepta Therapeutics, Inc. stock.

Analyst Consensus Rating

Investment consensus from 17 professional research analysts

Consensus Rating

Hold
Based on 17 unique analysts
(27 total ratings in last 90 days)
High Confidence0.8:1 Buy/Sell

Average Price Target

$21.53
+13.98% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest SRPT Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Ritu Baral
TD Cowen
HoldMaintains
$17.00
Mitchell Kapoor
HC Wainwright
SellReiterates
$5.00
Biren Amin
Piper Sandler
HoldMaintains
$20.00
Yun Zhong
Wedbush
BuyMaintains
$35.00
Unknown Analyst
Leerink Partners
HoldReiterates
$20.00
Tazeen Ahmad
BofA Securities
SellReiterates
$18.00
Brian Abrahams
RBC Capital
HoldMaintains
$17.00
Brian Abrahams
RBC Capital
HoldMaintains
$19.00 → $17.00
Mitchell Kapoor
HC Wainwright
SellReiterates
$5.00
Yanan Zhu
Wells Fargo
BuyMaintains
$38.00
Yun Zhong
Wedbush
BuyMaintains
$35.00
Anupam Rama
JP Morgan
HoldReiterates
$23.00 → $20.00
Lachlan Hanbury Brown
William Blair
HoldReiterates
-
Yigal Nochomovitz
Citi
SellMaintains
$13.00
Gil Blum
Needham
SellMaintains
-
Yigal Nochomovitz
Citi
SellMaintains
$13.00
Gavin Clark-Gartner
Evercore ISI Group
HoldMaintains
$19.00
Eliana Merle
Barclays
HoldMaintains
$20.00
Mitchell Kapoor
HC Wainwright
SellReiterates
$5.00
Biren Amin
Piper Sandler
HoldMaintains
$20.00
Ritu Baral
TD Cowen
HoldInitiates Coverage
$17.00
Yanan Zhu
Wells Fargo
BuyMaintains
$38.00
Kostas Biliouris
Oppenheimer
BuyMaintains
$37.00 → $35.00
Gil Blum
Needham
SellReiterates
-
Michael Ulz
Morgan Stanley
HoldInitiates Coverage
$25.00
Kristen Kluska
Cantor Fitzgerald
HoldMaintains
$21.00
Brian Abrahams
RBC Capital
HoldMaintains
$19.00

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 21, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for SRPT?

The analyst consensus rating for SRPT is Hold, based on the latest ratings from 17 analysts over the last 90 days.

What is the average price target for SRPT?

The average 12-month price target for SRPT is $21.53, representing an upside of 14.0% from the Oct 27, 2026 close of $18.89.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.